<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">Earlier, preparative method isolation and purification of the lipophilic compounds product (LCP) from 
 <italic>Еucalyptus viminalis</italic> plants was developed (
 <xref rid="bib53" ref-type="bibr">Savina et al., 1995</xref>). This product showed broad antimicrobial activity against a number of pathogenic microorganisms (
 <italic>Staphylococcus aureus, Streptococcus pyogenes, Bacillus subtilis, Bacillus anthracoides, Corynebacterium diphtheria</italic>), including the antibiotic resistant strains of 
 <italic>Streptococcus pneumonia</italic> (
 <xref rid="bib54" ref-type="bibr">Semkina et al., 2006</xref>; 
 <xref rid="bib69" ref-type="bibr">Vichkanova, 2012</xref>). High anti-inflammatory activity of the LCP was found also (
 <xref rid="bib66" ref-type="bibr">Tarasova et al., 1998</xref>). Further, the LCP was used for development of many medicinal preparations that widely using now in dermatology, stomatology, genecology, urology, proctology, and for the treatment of inflammatory diseases of the upper respiratory tract (
 <xref rid="bib54" ref-type="bibr">Semkina et al., 2006</xref>; 
 <xref rid="bib69" ref-type="bibr">Vichkanova, 2012</xref>). The study of pharmacologically active compounds in the LCP with application of thin layer chromatography showed that the product contain phloroglucinols and some triterpenoids (
 <xref rid="bib53" ref-type="bibr">Savina et al., 1995</xref>; 
 <xref rid="bib69" ref-type="bibr">Vichkanova, 2012</xref>). However, their detailed composition in the LCP was not investigated.
</p>
